Phoenix Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 16, 2025, 2:18 pm

Competitors of Phoenix Mills Ltd

All Competitor Stocks of Phoenix Mills Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:32 am

Below is a detailed analysis of the quarterly data for Phoenix Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,016.00 Cr.. The value appears strong and on an upward trend. It has increased from 975.00 Cr. (Dec 2024) to 1,016.00 Cr., marking an increase of 41.00 Cr..
• For Expenses, as of Mar 2025, the value is 457.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 422.00 Cr. (Dec 2024) to 457.00 Cr., marking an increase of 35.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 560.00 Cr.. The value appears strong and on an upward trend. It has increased from 553.00 Cr. (Dec 2024) to 560.00 Cr., marking an increase of 7.00 Cr..
• For OPM %, as of Mar 2025, the value is 55.00%. The value appears to be declining and may need further review. It has decreased from 57.00% (Dec 2024) to 55.00%, marking a decrease of 2.00%.
• For Other Income, as of Mar 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Dec 2024) to 42.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 94.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 103.00 Cr. (Dec 2024) to 94.00 Cr., marking a decrease of 9.00 Cr..
• For Depreciation, as of Mar 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Dec 2024) to 90.00 Cr., marking an increase of 9.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 418.00 Cr.. The value appears strong and on an upward trend. It has increased from 415.00 Cr. (Dec 2024) to 418.00 Cr., marking an increase of 3.00 Cr..
• For Tax %, as of Mar 2025, the value is 17.00%. The value appears to be increasing, which may not be favorable. It has increased from 15.00% (Dec 2024) to 17.00%, marking an increase of 2.00%.
• For Net Profit, as of Mar 2025, the value is 348.00 Cr.. The value appears to be declining and may need further review. It has decreased from 353.00 Cr. (Dec 2024) to 348.00 Cr., marking a decrease of 5.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 7.52. The value appears strong and on an upward trend. It has increased from 7.41 (Dec 2024) to 7.52, marking an increase of 0.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:45 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:34 pm

Below is a detailed analysis of the balance sheet data for Phoenix Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 72.00 Cr., marking an increase of 36.00 Cr..
• For Reserves, as of Mar 2025, the value is 10,377.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,422.00 Cr. (Mar 2024) to 10,377.00 Cr., marking an increase of 955.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,687.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4,639.00 Cr. (Mar 2024) to 4,687.00 Cr., marking an increase of 48.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 6,396.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,051.00 Cr. (Mar 2024) to 6,396.00 Cr., marking an increase of 1,345.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 21,531.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,148.00 Cr. (Mar 2024) to 21,531.00 Cr., marking an increase of 2,383.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 14,466.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,137.00 Cr. (Mar 2024) to 14,466.00 Cr., marking an increase of 1,329.00 Cr..
• For CWIP, as of Mar 2025, the value is 3,143.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,503.00 Cr. (Mar 2024) to 3,143.00 Cr., marking an increase of 1,640.00 Cr..
• For Investments, as of Mar 2025, the value is 1,465.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,725.00 Cr. (Mar 2024) to 1,465.00 Cr., marking a decrease of 260.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,457.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,782.00 Cr. (Mar 2024) to 2,457.00 Cr., marking a decrease of 325.00 Cr..
• For Total Assets, as of Mar 2025, the value is 21,531.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,148.00 Cr. (Mar 2024) to 21,531.00 Cr., marking an increase of 2,383.00 Cr..

Notably, the Reserves (10,377.00 Cr.) exceed the Borrowings (4,687.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Phoenix Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 27.53. This value is within the healthy range. It has decreased from 61.36 (Mar 24) to 27.53, marking a decrease of 33.83.
• For Diluted EPS (Rs.), as of Mar 25, the value is 27.52. This value is within the healthy range. It has decreased from 61.31 (Mar 24) to 27.52, marking a decrease of 33.79.
• For Cash EPS (Rs.), as of Mar 25, the value is 45.54. This value is within the healthy range. It has decreased from 89.34 (Mar 24) to 45.54, marking a decrease of 43.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 292.24. It has decreased from 693.21 (Mar 24) to 292.24, marking a decrease of 400.97.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 292.24. It has decreased from 693.21 (Mar 24) to 292.24, marking a decrease of 400.97.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 106.67. It has decreased from 222.59 (Mar 24) to 106.67, marking a decrease of 115.92.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 64.67. This value is within the healthy range. It has decreased from 129.21 (Mar 24) to 64.67, marking a decrease of 64.54.
• For PBIT / Share (Rs.), as of Mar 25, the value is 55.54. This value is within the healthy range. It has decreased from 114.09 (Mar 24) to 55.54, marking a decrease of 58.55.
• For PBT / Share (Rs.), as of Mar 25, the value is 44.62. This value is within the healthy range. It has decreased from 91.94 (Mar 24) to 44.62, marking a decrease of 47.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 36.40. This value is within the healthy range. It has decreased from 74.22 (Mar 24) to 36.40, marking a decrease of 37.82.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 64.10. This value is within the healthy range. It has increased from 61.51 (Mar 24) to 64.10, marking an increase of 2.59.
• For PBDIT Margin (%), as of Mar 25, the value is 60.62. This value is within the healthy range. It has increased from 58.04 (Mar 24) to 60.62, marking an increase of 2.58.
• For PBIT Margin (%), as of Mar 25, the value is 52.06. This value exceeds the healthy maximum of 20. It has increased from 51.25 (Mar 24) to 52.06, marking an increase of 0.81.
• For PBT Margin (%), as of Mar 25, the value is 41.82. This value is within the healthy range. It has increased from 41.30 (Mar 24) to 41.82, marking an increase of 0.52.
• For Net Profit Margin (%), as of Mar 25, the value is 34.12. This value exceeds the healthy maximum of 10. It has increased from 33.34 (Mar 24) to 34.12, marking an increase of 0.78.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 60.08. This value exceeds the healthy maximum of 20. It has increased from 27.63 (Mar 24) to 60.08, marking an increase of 32.45.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.93. This value is within the healthy range. It has increased from 11.62 (Mar 24) to 21.93, marking an increase of 10.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 10.36. This value is within the healthy range. It has decreased from 11.96 (Mar 24) to 10.36, marking a decrease of 1.60.
• For Return On Assets (%), as of Mar 25, the value is 10.64. This value is within the healthy range. It has increased from 5.70 (Mar 24) to 10.64, marking an increase of 4.94.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 0.40 (Mar 24) to 0.36, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.44. This value is within the healthy range. It has decreased from 0.48 (Mar 24) to 0.44, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.21 (Mar 24) to 0.18, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 1.5. It has decreased from 1.51 (Mar 24) to 1.14, marking a decrease of 0.37.
• For Quick Ratio (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.81, marking a decrease of 0.35.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.27, marking an increase of 0.27.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.13 (Mar 24) to 0.00, marking a decrease of 8.13.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.52 (Mar 24) to 0.00, marking a decrease of 6.52.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.87 (Mar 24) to 0.00, marking a decrease of 91.87.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.48 (Mar 24) to 0.00, marking a decrease of 93.48.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.73. This value is within the healthy range. It has decreased from 5.83 (Mar 24) to 5.73, marking a decrease of 0.10.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.20. This value is within the healthy range. It has decreased from 4.35 (Mar 24) to 4.20, marking a decrease of 0.15.
• For Enterprise Value (Cr.), as of Mar 25, the value is 66,162.71. It has increased from 56,345.38 (Mar 24) to 66,162.71, marking an increase of 9,817.33.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 17.35. This value exceeds the healthy maximum of 3. It has increased from 14.17 (Mar 24) to 17.35, marking an increase of 3.18.
• For EV / EBITDA (X), as of Mar 25, the value is 28.62. This value exceeds the healthy maximum of 15. It has increased from 24.40 (Mar 24) to 28.62, marking an increase of 4.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 15.37. This value exceeds the healthy maximum of 3. It has increased from 12.45 (Mar 24) to 15.37, marking an increase of 2.92.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.86 (Mar 24) to 0.00, marking a decrease of 91.86.
• For Price / BV (X), as of Mar 25, the value is 5.61. This value exceeds the healthy maximum of 3. It has increased from 5.24 (Mar 24) to 5.61, marking an increase of 0.37.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 15.37. This value exceeds the healthy maximum of 3. It has increased from 12.45 (Mar 24) to 15.37, marking an increase of 2.92.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness